We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Arthroscopic Knee Surgery Called Unnecessary

By HospiMedica International staff writers
Posted on 29 Sep 2008
A new study claims that one of the most common orthopedic surgical procedures performed, arthroscopy to treat arthritis in the knee, is useless, conferring no added benefits when compared to drugs or physical therapy.

Researchers at of the University of Western Ontario (London, Canada) conducted a single-center, randomized controlled trial of arthroscopic surgery in 178 patients with moderate-to-severe osteoarthritis (OA) of the knee. More...
All patients received standard nonsurgical treatment, including physical therapy, painkillers such as acetaminophen and ibuprofen, glucosamine supplements, and injections to lubricate the joint. Patients were then randomly assigned to additional surgical lavage and arthroscopic debridement, or to continued treatment with physical and medical therapy alone. The primary outcome was the total Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score at 2 years of follow-up. Secondary outcomes included the Short Form-36 (SF-36) physical component summary score.

The study results showed that of the 92 patients assigned to surgery, six did not undergo surgery. Of the 86 patients assigned to control treatment, all received only physical and medical therapy. After 2 years, the mean WOMAC score for the surgery group was 874(+/- 624), as compared with 897 (+/- 583) for the control group. The SF-36 physical component summary scores were an average 37 and 37.2 respectively. Analyses of WOMAC scores at interim visits and other secondary outcomes also failed to show any superiority of surgery. The study was published in the September 11, 2008, issue of the New England Journal of Medicine (NEJM).

"This study provides definitive evidence that arthroscopic surgery provides no additional therapeutic value when added to physical therapy and medication for patients with moderate osteoarthritis of the knee,” said lead author Brian Feagan, M.D., a professor in the departments of medicine and epidemiology and biostatistics. "If it isn't effective, patients should not be undergoing it.”

The researchers stressed that surgery could help people who have problems other than arthritis, such as a badly torn ligament or cartilage. They added that they hope the new research will encourage surgeons to be much more selective in offering the operations, and that patients will be less aggressive about demanding it.

Related Links:
University of Western Ontario


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.